Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell–mediated antitumor immunity-Reference-Cited by-同舟云学术

Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell–mediated antitumor immunity

Published:2022-11-15 Issue:22 Volume:132 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Ren Xiaoxin^ORCID,Peng Mou,Xing Peng,Wei Yao^ORCID,Galbo Phillip M.,Corrigan Devin,Wang Hao^ORCID,Su Yingzhen,Dong Xiaoshen,Sun Qizhe^ORCID,Li Yixian^ORCID,Zhang Xiaoyu,Edelmann Winfried,Zheng Deyou^ORCID,Zang Xingxing^ORCID

Funder

National Institutes of Health

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/163620/files/pdf

Reference68 articles.

1. Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential

2. Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

3. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

4. Mechanisms of resistance to immune checkpoint inhibitors

5. Functions of natural killer cells

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint pathways in glioblastoma: a diverse and evolving landscape;Frontiers in Immunology;2024-09-13

2. HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis;Frontiers in Immunology;2024-07-10

3. TOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors;Science Advances;2024-05-10

4. IGSF8 is an innate immune checkpoint and cancer immunotherapy target;Cell;2024-05

5. Mechanism study of tyrosine phosphatase shp-1 in inhibiting hepatocellular carcinoma progression by regulating the SHP2/GM-CSF pathway in TAMs;Scientific Reports;2024-04-21